CellCarta has acquired the commercial rights to the antibody panels and assays from Precision Assays, a Seattle, Washington-based targeted proteomics testing solutions provider.
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
10 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
10 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
11 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
11 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
11 hours ago · 2 mins read
Novacap completes OSI Maritime Systems acquisition as first Fund VII deal
11 hours ago · 2 mins read
Long Arc-backed Robertson Stephens adds Denver adviser Altius Financial
11 hours ago · 1 min read
